A team of Rutgers scientists have taken an important step toward the goal of making diseased hearts heal themselves – a new model that would reduce the need for bypass surgery, heart transplants or artificial pumping devices.
February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2019. This is based on website’s record 272,495 pageviews for the month:
Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available in the United States, European, Middle Eastern, African and Asia-Pacific markets. The device is the first specifically designed to achieve hemostasis of the radial artery during procedures where access is gained via the distal radial artery.
Cardiovascular Systems Inc. announced that the first patients in the United States were treated using the OrbusNeich Teleport Microcatheter (Teleport), which recently received U.S. Food and Drug Administration (FDA) 510(k) clearance.
Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target of widely prescribed drugs to regulate blood pressure and kidney function. The study, published online Jan. 10 in Cell, was conducted by researchers in the Blavatnik Institute at Harvard Medical School and colleagues at Duke University Medical Center.
The higher expense and lower frame rates of 3-D cardiac ultrasound systems have limited their adoption over the past decade and have begged the question at the annual American Society of Echocardiography (ASE) meetings whether 3-D is a necessary technology. However, sessions at ASE 2018 showed the focus on 3-D imaging systems has definitely changed from a research tool to a front-line echo workhorse.
If you enjoy this content, please share it with a colleague